BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
194 results:

  • 1. Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells.
    Zhang T; Zhou C; Lv M; Yu J; Cheng S; Cui X; Wan X; Ahmad M; Xu B; Qin J; Meng X; Luo H
    Eur J Pharm Sci; 2024 Mar; 194():106706. PubMed ID: 38244809
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. NDUFA8 is transcriptionally regulated by EP300/H3K27ac and promotes mitochondrial respiration to support proliferation and inhibit apoptosis in cervical cancer.
    Xiang H; Tang H; He Q; Sun J; Yang Y; Kong L; Wang Y
    Biochem Biophys Res Commun; 2024 Jan; 693():149374. PubMed ID: 38096616
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance.
    Sun Y; Zhou X; Lucas E; Chen L; Zhang H; Chen H; Zhou F
    J Pathol Clin Res; 2024 Jan; 10(1):e345. PubMed ID: 37798754
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
    Nyabigambo A; Mayega RW; Ginindza TG
    Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623195
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Enhanced Chemodynamic Therapy Mediated by a Tumor-Specific Catalyst in Synergy with Mitophagy Inhibition Improves the Efficacy for Endometrial cancer.
    Gong X; Wang J; Yang L; Li L; Gao X; Sun X; Bai J; Liu J; Pu X; Wang Y
    Small; 2023 Aug; 19(33):e2301497. PubMed ID: 37086131
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
    Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
    Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
    [No Abstract]    [Full Text] [Related]  

  • 7. uterine Sarcoma With fgfr1-TACC1 Gene Fusion: A Case Report and Review of the Literature.
    Zyla RE; Goebel EA; Jang JH; Turashvili G
    Int J Gynecol Pathol; 2022 Nov; 41(6):588-592. PubMed ID: 36302190
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification and verification of a 4-gene signature predicting the overall survival of cervical cancer.
    Yuan L; Lu Z; Sun G; Cao D
    Medicine (Baltimore); 2022 Oct; 101(42):e31299. PubMed ID: 36281082
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Loss of LOXL2 Promotes uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.
    Lu X; Xin DE; Du JK; Zou QC; Wu Q; Zhang YS; Deng W; Yue J; Fan XS; Zeng Y; Cheng X; Li X; Hou Z; Mohan M; Zhao TC; Lu X; Chang Z; Xu L; Sun Y; Zu X; Zhang Y; Chinn YE
    Cancer Res; 2022 Dec; 82(23):4400-4413. PubMed ID: 36197797
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma.
    Chen H; Molberg K; Carrick K; Niu S; Rivera Colon G; Gwin K; Lewis C; Zheng W; Castrillon DH; Lucas E
    Mod Pathol; 2022 Dec; 35(12):1955-1965. PubMed ID: 35804040
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci.
    Sudarshan D; Avvakumov N; Lalonde ME; Alerasool N; Joly-Beauparlant C; Jacquet K; Mameri A; Lambert JP; Rousseau J; Lachance C; Paquet E; Herrmann L; Thonta Setty S; Loehr J; Bernardini MQ; Rouzbahman M; Gingras AC; Coulombe B; Droit A; Taipale M; Doyon Y; Côté J
    Genes Dev; 2022 Jun; 36(11-12):664-683. PubMed ID: 35710139
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pricing of HPV tests in Italian tender-based settings.
    Inturrisi F; Berkhof J
    J Med Econ; 2022; 25(1):762-768. PubMed ID: 35616231
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer.
    Ronchetti L; Terrenato I; Ferretti M; Corrado G; Goeman F; Donzelli S; Mandoj C; Merola R; Zampa A; Carosi M; Blandino G; Conti L; Lobascio AM; Iacobelli M; Vizza E; Piaggio G; Gurtner A
    J Exp Clin Cancer Res; 2022 Apr; 41(1):151. PubMed ID: 35449078
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lung metastases and subsequent malignant transformation of a fumarate hydratase -deficient uterine leiomyoma.
    Ahvenainen T; Khamaiseh S; Alkodsi A; Mehine M; Nevala R; Äyräväinen A; Bützow R; Vahteristo P
    Exp Mol Pathol; 2022 Jun; 126():104760. PubMed ID: 35367216
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells.
    Rocha MA; de Campos Vidal B; Mello MLS
    Curr Mol Pharmacol; 2023; 16(2):197-210. PubMed ID: 35297358
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer.
    Inoue F; Sone K; Toyohara Y; Tanimoto S; Takahashi Y; Kusakabe M; Kukita A; Honjoh H; Nishijima A; Taguchi A; Miyamoto Y; Tanikawa M; Iriyama T; Uchino MM; Tsuruga T; Wada-Hiraike O; Oda K; Osuga Y
    Biochem Biophys Res Commun; 2022 Apr; 601():123-128. PubMed ID: 35245741
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ARID1A loss-of-function induces CpG island methylator phenotype.
    Yamada H; Takeshima H; Fujiki R; Yamashita S; Sekine S; Ando T; Hattori N; Okabe A; Yoshikawa T; Obama K; Katai H; Kaneda A; Ushijima T
    Cancer Lett; 2022 Apr; 532():215587. PubMed ID: 35131383
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. FGF signalling facilitates cervical cancer progression.
    Mahmood HA; Tomas Bort E; Walker AJ; Grose RP; Chioni AM
    FEBS J; 2022 Jun; 289(12):3440-3456. PubMed ID: 34951738
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Non-coding RNAs-EZH2 regulatory mechanisms in cervical cancer: The current state of knowledge.
    Zheng J; Chen L
    Biomed Pharmacother; 2022 Feb; 146():112123. PubMed ID: 34915417
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression of B7 family checkpoint proteins in cervical cancer.
    Zong L; Gu Y; Zhou Y; Kong Y; Mo S; Yu S; Xiang Y; Chen J
    Mod Pathol; 2022 Jun; 35(6):786-793. PubMed ID: 34848831
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.